TrademarkDir
CUREPHARMA
LIVE

Serial Number

79300671

Owner

CUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.

Attorney

Alexander Reid

Filing Date

Jul 23, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CUREPHARMA Trademark

Serial Number: 79300671 • Registration: 6648799

CUREPHARMA is a trademark filed by CUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD. on July 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.

Room 2606, No 763 Mengzi Road,

Entity Type: 99

Trademark Details

Filing Date

July 23, 2020

Registration Date

February 22, 2022

Published for Opposition

December 7, 2021

Cancellation Date

October 3, 2023

Goods & Services

Pharmaceutical substances and preparations for the treatment of neurodegenerative conditions, diseases, and disorders

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 22, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 22, 2023 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 22, 2022 FINV
GENERIC MADRID TRANSACTION SENT TO IB
Jul 27, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Jul 27, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 22, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 22, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Dec 13, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2021 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Aug 6, 2021 NREP
ATTORNEY REVIEW COMPLETED
Jun 22, 2021 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
May 18, 2021 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
May 16, 2021 CRCV
REFUSAL PROCESSED BY IB
May 3, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 10, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 10, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 7, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 6, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 1, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 24, 2020 REPR

Related Trademarks